Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,96 USD | +10,73 % |
|
+2,08 % | -52,71 % |
14/05 | LEAP THERAPEUTICS, INC. : HC Wainwright mantiene su recomendación de compra | ZM |
13/05 | Leap Therapeutics, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 | CI |
Resumen de negocios
Número de empleados: 54
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Doug Onsi
CEO | Chief Executive Officer | 55 | 01/01/11 |
Chris Mirabelli
CHM | Chairman | 69 | 01/01/11 |
Jason Baum
CTO | Chief Tech/Sci/R&D Officer | 45 | 24/08/20 |
Michael Haas
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cynthia Sirard
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/01/12 |
Augustine Lawlor
COO | Chief Operating Officer | 67 | 01/01/16 |
General Counsel | 56 | 24/08/20 | |
Jonathan Miller
PRN | Corporate Officer/Principal | - | 01/01/20 |
Mark O’Mahony
PRN | Corporate Officer/Principal | 53 | 01/01/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Loscalzo
BRD | Director/Board Member | 72 | 01/01/16 |
Nissim Mashiach
BRD | Director/Board Member | 63 | 01/01/17 |
Chris Mirabelli
CHM | Chairman | 69 | 01/01/11 |
James Cavanaugh
BRD | Director/Board Member | 87 | 01/01/16 |
Thomas Dietz
BRD | Director/Board Member | 60 | 01/01/16 |
Doug Onsi
CEO | Chief Executive Officer | 55 | 01/01/11 |
Chris Richard
BRD | Director/Board Member | 54 | 17/01/23 |
Patricia Martin
BRD | Director/Board Member | 63 | 01/01/23 |
Richard Schilsky
BRD | Director/Board Member | 73 | 01/09/22 |
William Li
BRD | Director/Board Member | 61 | 01/01/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 38 264 518 | 32 856 169 ( 85,87 %) | 54 ( 0,000141 %) | 85,87 % |
Información de la empresa
Leap Therapeutics, Inc.
47 Thorndike Street Suite B1-1
02141, Cambridge
+617 714 0360
http://www.leaptx.com![Dirección Leap Therapeutics, Inc.(LPTX)](https://cdn.zonebourse.com/static/address/33375941.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-52,71 % | 67,73 M | |
+15,20 % | 122 mil M | |
+19,67 % | 113 mil M | |
+18,95 % | 26,49 mil M | |
-23,86 % | 19,4 mil M | |
-19,03 % | 16,24 mil M | |
-20,90 % | 15,4 mil M | |
-46,14 % | 15,15 mil M | |
+63,85 % | 14,93 mil M | |
+4,49 % | 13,52 mil M |
- Bolsa de valores
- Acciones
- Acción LPTX
- Empresa Leap Therapeutics, Inc.